About this trial
This study aims to assess the ultrasound (US) and nerve conduction studies (NCS) as a tool for diagnosis, treatment planning and follow-up of patients with carpal tunnel syndrome (CTS).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years old.
Both sexes.
Patients with carpal tunnel syndrome.
Disqualifiers
History of wrist surgery (including carpal tunnel injection) or fracture.
Clinical or electrophysiological evidence of an accompanying condition that mimics carpal tunnel syndrome or interferes with its evaluation, such as proximal median neuropathy, cervical radiculopathy or polyneuropathy.
History of underlying disorders associated with carpal tunnel syndrome such as diabetes mellitus, rheumatoid arthritis, pregnancy, acromegaly or hypothyroidism.
Electrodiagnostic findings suggestive of co-existing neurological disorders.
Trial population
This retrospective study will be carried out on 60 patients with CTS admitted in KafrElsheikh University Hospitals over a period of 6 months starting from approval of the Medical Sciences Ethics Committee of KafrElsheikh Faculty of Medicine and all the included patients will provide written informed consent.
Trial design
Other
Retrospective
Treatments tested in this trial
Ultrasound
Procedure/SurgeryAll patients underwent high-resolution real-time sonography of the carpal tunnel (both hands) using an Ultrasound (US) machine and a 12 MHz linear array transducer. US examination will be performed before and 3 months after surgery.
Treatment groups
Trial outcomes
Primary outcomes
Sensitivity of ultrasound in diagnosis of carpal tunnel syndrome
Sensitivity of ultrasound in diagnosis of carpal tunnel syndrome will be recorded.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.